(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CIPRALEX

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CIPRALEX

ST13

US500000079388483

Classe

9, 35

Pedido

79388483

Registro

7846396

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

44

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 35

Data de depósito

23/11/2023

Data de registro

01/07/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

01/07/2025

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

DK

Examinador

WOLFSEN, CHRISTIANNE LISBETH

Unidade examinadora

O20

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

H. Lundbeck A/S

Representantes

Maren C. Perry King & Spalding LLP

Classificação técnica

Classes Nice

Classe 9Classe 35

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable electronic publications in the nature of booksreportsbrochuresbookletsmagazinesincluding leafletsmagazinesjournalsteaching and training material in research and developmentscienceclinical testsdiagnosticsmedicinepharmaceuticalsdisordersdiseasestreatment and prevention; Computer softwarerecordedbeing software for storing and analyzing medical and pharmaceutical informationcreating and delivering learning and training management programs and systemsproviding customer relationship management and sales force automation tools including sales trackingscheduling and reporting sales activities; Recorded and downloadable computer networking software for accessing websitesintranets and the Internet; Downloadable software in the form of downloadable virtual goods authenticated by non-fungible tokens (NFTs)image files of pharmaceutical preparations and substancesincluding for use in online environmentsvirtual environmentsaugmented virtual reality environments and metaverses; Downloadable computer software for creating searchable databases of information and data in the field of digital advice; Downloadable software in the nature of a mobile application for creating searchable databases of information and data in the field of digital advice; Downloadable digital image files containing images of pharmaceuticals and pharmaceutical substances authenticated by non-fungible tokens (NFTs); Downloadable software for preparingmanagingstoringmaking availablesendingreceivingexchangingvalidating and selling virtual pharmaceutical preparations and substances

Classe 35

Wholesale and retail store services featuring pharmaceuticals; advertising agency services in the field of research and developmentscienceclinical testsdiagnosticsmedicinepharmaceuticalsdisordersdiseasestreatment and prevention; provision of the aforementioned services onlinevia cable or Internet or other electronic media; online retail store services featuring digital files as well as virtual goods in the form of pharmaceutical preparations and substancesgoods and files authenticated by NFTs (non-fungible tokens); providing an online marketplace for buyers and sellers of digital files and virtual goods in the form of pharmaceutical preparations and substancesgoods and files authenticated by NFTs (non-fungible tokens)

Publicações

Histórico de despachos e eventos da marca no USPTO.

44 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/02/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

27/01/2026

FIMP

FINAL DISPOSITION PROCESSED

27/01/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/10/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

15/08/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

25/07/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

25/07/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/07/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

13/05/2025

PUBO

PUBLISHED FOR OPPOSITION

13/05/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/05/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/04/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/04/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/04/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/04/2025

RFNP

REFUSAL PROCESSED BY IB

15/02/2025

CNRT

NON-FINAL ACTION WRITTEN

09/01/2025

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

03/01/2025

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

03/12/2024

RFNP

REFUSAL PROCESSED BY IB

30/11/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

18/11/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/11/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/11/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

17/11/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/11/2024

RFRR

REFUSAL PROCESSED BY MPU

11/11/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

30/10/2024

CNRT

NON-FINAL ACTION WRITTEN

29/10/2024

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

28/10/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

23/10/2024

CNRT

NON-FINAL ACTION WRITTEN

22/10/2024

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

22/10/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

15/10/2024

CNRT

NON-FINAL ACTION WRITTEN

04/06/2024

DOCK

ASSIGNED TO EXAMINER

28/05/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

18/03/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

18/03/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

18/03/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

18/03/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

18/03/2024

MAFR

APPLICATION FILING RECEIPT MAILED

06/02/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/02/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/02/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CIPRALEX ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.